Postprandial glycaemic excursions and cardiovascular risk. Keywords : ['postprandial glycaemic excursion', 'cardiovascular risk'] Author : R Pradeepa 3
Postprandial glycaemic excursions and cardiovascular risk. Keywords : ['postprandial glycaemic excursion', 'cardiovascular risk'] Author : R Pradeepa 3
Postprandial glycaemic excursions and cardiovascular risk. Keywords : ['postprandial glycaemic excursion', 'cardiovascular risk'] Author : R Pradeepa 3
Postprandial glycaemic excursions and cardiovascular risk. Keywords : ['postprandial glycaemic excursion', 'cardiovascular risk'] Author : R Pradeepa 3
Postprandial glycaemic excursions and cardiovascular risk. Keywords : ['postprandial glycaemic excursion', 'cardiovascular risk'] Author : R Pradeepa 3
Postprandial glycaemic excursions and cardiovascular risk. Keywords : ['postprandial glycaemic excursion', 'cardiovascular risk'] Author : R Pradeepa 3
Does aggressive glycemic control benefit macrovascular and microvascular disease in type 2 diabetes? Insights from ACCORD, ADVANCE, and VADT. Keywords : ['aggressive glycemic control benefit macrovascular', 'type diabete insight', 'microvascular disease', 'accord advance', 'vadt'] Author : T Terry 3
Does aggressive glycemic control benefit macrovascular and microvascular disease in type 2 diabetes? Insights from ACCORD, ADVANCE, and VADT. Keywords : ['aggressive glycemic control benefit macrovascular', 'type diabete insight', 'microvascular disease', 'accord advance', 'vadt'] Author : T Terry 3
Does aggressive glycemic control benefit macrovascular and microvascular disease in type 2 diabetes? Insights from ACCORD, ADVANCE, and VADT. Keywords : ['aggressive glycemic control benefit macrovascular', 'type diabete insight', 'microvascular disease', 'accord advance', 'vadt'] Author : T Terry 3
Does aggressive glycemic control benefit macrovascular and microvascular disease in type 2 diabetes? Insights from ACCORD, ADVANCE, and VADT. Keywords : ['aggressive glycemic control benefit macrovascular', 'type diabete insight', 'microvascular disease', 'accord advance', 'vadt'] Author : T Terry 3